Skip to main content
Clinical Trials/NCT03758599
NCT03758599
Completed
Not Applicable

Exercise in Anxiety and Posttraumatic Stress Disorders - a Randomized Controlled Clinical Pilot Trial

Universitaet Innsbruck1 site in 1 country60 target enrollmentOctober 1, 2017
ConditionsAnxiety

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anxiety
Sponsor
Universitaet Innsbruck
Enrollment
60
Locations
1
Primary Endpoint
Change from Baseline (t1) Symptoms of Anxiety at four weeks (t2), three months after intervention (t3) and six months after intervention (t4)
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Aim: Aerobic and resistance exercise showed anxiolytic effects in clinical populations. Climbing could further enhance self-efficacy. Aim of the study is to examine whether climbing exercise and aerobic exercise, compared to social contact control, reduces symptoms of disease in out-patients with anxiety disorder (AD) and post-traumatic stress disorder (PTSD). Further analyses are aiming to reveal differences between climbing - and aerobic exercise.

Design: Randomized controlled clinical trial Participants: Thirty out-patients diagnosed with International Classification of Disease-Version 10 (ICD-10) (F40, F41, F43.1) for AD or PTSD.

Intervention: Out-patients will be assigned randomly to a climbing exercise group (a), aerobic exercise group (Nordic walking) (b) or social contact control group (c).

Measurements: Primary outcome is symptom severity in AD or Post Traumatic Stress Disorders. Further secondary outcomes are evaluated by psychological questionnaires assessing depression, worry symptoms, quality of life, self-efficacy and affective responses. Metabolites of neurotransmitters, immune-activation markers and anthropometric data will be additionally provided as secondary physiological outcomes.

Duration: Intervention duration is four weeks with 2 x 75 min for every group (climbing exercise, aerobic exercise, social contact control). Measurement points are set at the beginning (t1), at the end of the intervention (t2) and 3 (t3) and 6 (t4) months follow-up.

Detailed Description

The proposed research project is designed as a randomized controlled clinical trial with three arms. The efficacy of a climbing exercise program, an aerobic exercise program and a social contact control group on primary and secondary study outcome will be investigated (see Figure 1). Patients will be first screened by the outpatient-unit of the Department of Psychosomatics at the Medical University of Innsbruck or remitted through the treating staff network community. When assessed as eligible for the study, a group of up to ten out-patients will be randomly selected and invited to an informative meeting. Patients receive study information and time tables for their group attendances. The intervention will start within the following week and will end four weeks after beginning. Follow-up assessments will take place three and six months after intervention. In addition to the AD/PTSD symptom screening, secondary study outcomes will be assessed: * at study inclusion (t1) * at the end of the intervention (t2) * three months after the intervention (t3) * six months after the intervention (t4)

Registry
clinicaltrials.gov
Start Date
October 1, 2017
End Date
December 1, 2020
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Universitaet Innsbruck
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • ICD-10 diagnosis of Anxiety Disorder or Post Traumatic Stress Disorder: F40, F41, F43.1;
  • age range: 18-65
  • written informed consent
  • stable medication (if needed) for at least 3 weeks

Exclusion Criteria

  • acute psychosis or suicidal behaviour
  • medical contraindication to physical activity (assessed by a clinician)
  • cognitive deficits
  • problems with German language

Outcomes

Primary Outcomes

Change from Baseline (t1) Symptoms of Anxiety at four weeks (t2), three months after intervention (t3) and six months after intervention (t4)

Time Frame: 1 hour before intervention, after 672 hours, after 2328 hours, after 4488 hours

Beck Anxiety Inventory (BAI; Beck \& Steer, 1990) The BAI ranges from 0 and 63 points with lower points indicating less symptoms of anxiety

Change from Baseline (t1) Symptoms of Posttraumatic Stress Disorder at four weeks (t2), three months after intervention (t3) and six months after intervention (t4)

Time Frame: 1 hour before intervention, after 672 hours, after 2328 hours, after 4488 hours

Post Traumatic Stress Disorder Checklist Civil Version (PCL-5; Weathers et al., 2013) The PCL-5 ranges from 0 and 80 points with lower points indicating less symptoms of PTSD The PCL-5 ranges from 0 and 80 points with lower points indicating less symptoms of Posttraumatic Stress Disorder

Secondary Outcomes

  • Change from Baseline (t1) Analyses of neurotransmitter metabolites at four weeks (t2), three months after intervention (t3) and six months after intervention (t4)(1 hour before intervention, after 672 hours, after 2328 hours, after 4488 hours)
  • Affective Responses_d(38 minutes after beginning of intervention)
  • Change from Baseline (t1) Depression at four weeks (t2), three months after intervention (t3) and six months after intervention (t4)(1 hour before intervention, after 672 hours, after 2328 hours, after 4488 hours)
  • Change from Baseline (t1) Worry Symptoms at four weeks (t2), three months after intervention (t3) and six months after intervention (t4)(1 hour before intervention, after 672 hours, after 2328 hours, after 4488 hours)
  • Change from Baseline (t1) Quality of Life (WHO) at four weeks (t2), three months after intervention (t3) and six months after intervention (t4)(1 hour before intervention, after 672 hours, after 2328 hours, after 4488 hours)
  • Change from Baseline (t1) Self Efficacy at four weeks (t2), three months after intervention (t3) and six months after intervention (t4)(1 hour before intervention, after 672 hours, after 2328 hours, after 4488 hours)
  • Affective Responses_a(1 minute before each intervention, after 38 minutes, after 75 minutes)
  • Affective Responses_b(1 minute before each intervention, after 38 minutes, after 75 minutes)
  • Affective Responses_c(1 minute before each intervention, after 75 minutes)
  • Change from Baseline (t1) Analyses of immune-activation markers at four weeks (t2), three months after intervention (t3) and six months after intervention (t4)(1 hour before intervention, after 672 hours, after 2328 hours, after 4488 hours)

Study Sites (1)

Loading locations...

Similar Trials